Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer
Authors:
Open Access
- 1 February 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 6 (2) , 542-551
Abstract
Through genome-wide expression profile analysis for non–small cell lung cancers (NSCLC), we found overexpression of a Myc-associated protein with JmjC domain (MAPJD) gene in the great majority of NSCLC cases. Induction of exogenous expression of MAPJD into NIH3T3 cells conferred growth-promoting activity. Concordantly, in vitro suppression of MAPJD expression with small interfering RNA effectively suppressed growth of NSCLC cells, in which MAPJD was overexpressed. We found four candidate MAPJD target genes, SBNO1, TGFBRAP1, RIOK1, and RASGEF1A, which were the most significantly induced by exogenous MAPJD expression. Through interaction with MYC protein, MAPJD transactivates a set of genes, including kinases and cell signal transducers that are possibly related to proliferation of lung cancer cells. As our data imply that MAPJD is a novel member of the MYC transcriptional complex and its activation is a common feature of lung cancer, selective suppression of this pathway could be a promising therapeutic target for treatment of lung cancers. [Mol Cancer Ther 2007;6(2):542–51]Keywords
This publication has 39 references indexed in Scilit:
- Increased Expression of Insulin-like Growth Factor-II Messenger RNA–Binding Protein 1 Is Associated with Tumor Progression in Patients with Lung CancerClinical Cancer Research, 2007
- Activation of CDCA1-KNTC2, Members of Centromere Protein Complex, Involved in Pulmonary CarcinogenesisCancer Research, 2006
- Characterization of SEZ6L2 cell‐surface protein as a novel prognostic marker for lung cancerCancer Science, 2006
- A Novel Human tRNA-Dihydrouridine Synthase Involved in Pulmonary CarcinogenesisCancer Research, 2005
- ADAM8 as a Novel Serological and Histochemical Marker for Lung CancerClinical Cancer Research, 2004
- NO66, a Highly Conserved Dual Location Protein in the Nucleolus and in a Special Type of Synchronously Replicating ChromatinMolecular Biology of the Cell, 2004
- The nucleolus: a site of ribonucleoprotein maturationCurrent Opinion in Cell Biology, 2003
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- MYC oncogenes and human neoplastic diseaseOncogene, 1999
- Sequence-Specific DNA Binding by the c-Myc ProteinScience, 1990